Post-approval studies (Phase 4)Study completedNCT02683265
What this trial is testing
A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD
Who this might be right for
Attention Deficit Disorder With Hyperactivity
Rhodes Pharmaceuticals, L.P. 158